Journal of Clinical & Experimental Pharmacology

Liang Li

Liang Li
Clinical Pharmacology Reviewer in Division of Clinical Pharmacology, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA)
USA

Biography

Dr. Liang Li is currently a Clinical Pharmacology Reviewer in Division of Clinical Pharmacology V, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA). Dr. Liang Li obtained his B.S., M.S. and Ph.D. degrees in Clinical Pharmacology and Pharmacometrics in 2006, 2008, and 2011 respectively, from Peking University, Beijing, China. Before he joined U.S. FDA in 2014, Dr. Liang Li was an Assistant Professor in Division of Pharmaceutics, Peking University, and a Visiting Scholar in Pfizer's China Research and Development Center, Shanghai, China. Dr. Liang Li has extensive experience in Clinical Pharmacology and Pharmacometrics from academic, industrial, regulatory perspectives. He has published more than 50 peer-reviewed research articles.

Research Interest

Clinical Pharmacology; Pharmacometrics; System Pharmacology; Pharmacokinetics; Pharmacodynamics; Model-based meta-analysis; Drug-drug interaction